Advisor Group Holdings, Inc. Biodesix Inc Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.24 - $2.89 $282 - $658	-228 Reduced 18.98%	973 $1,000
Q2 2022 Aug 10, 2022	SELL	$1.32 - $2.12 $689 - $1,106	-522 Reduced 30.3%	1,201 $2,000
Q1 2022 May 04, 2022	BUY	$1.69 - $5.81 $1,933 - $6,646	1,144 Added 197.58%	1,723 $3,000
Q3 2021 Nov 05, 2021	BUY	$6.6 - $12.78 $1,452 - $2,811	220 Added 61.28%	579 $4,000
Q2 2021 Aug 02, 2021	BUY	$12.14 - $20.35 $1,238 - $2,075	102 Added 39.69%	359 $5,000
Q1 2021 May 13, 2021	BUY	$16.87 - $31.21 $4,335 - $8,020	257 New	257 $5,000

62.3M

2.6K

10.1K

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $55.2M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.